Welcome to our dedicated page for Forian SEC filings (Ticker: FORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Forian Inc. SEC filings document the company's healthcare data analytics business, financial reporting, governance actions and capital-structure matters. Its Form 8-K disclosures include operating and financial results, material-event reports, accounting-firm changes, board changes, and exhibits furnished with earnings releases.
The filing record also covers corporate governance and shareholder-rights matters, including proxy materials for a statutory redomiciliation and the completed change of domicile from Delaware to Maryland. Related disclosures describe charter and bylaw changes, stockholder voting mechanics, material agreements, internal-control topics, and other formal records affecting Forian's public-company structure.
Forian Inc. director Shahir Kassam-Adams reported disposing of his remaining equity interests in connection with the company’s merger. On May 15, 2026, a tender offer by 2025 Acquisition Company, LLC and a subsequent merger closed, leaving Forian as a wholly owned subsidiary of Parent.
The filing shows the return of 5,000 shares of common stock held directly, 171,184 shares held indirectly through 360 Ventures, LLC, and 75,000 stock options with various exercise prices. At the effective time of the merger, these shares and options were canceled, leaving Kassam-Adams with no reported Forian holdings.
Forian Inc. executive chairman, CEO and president Max C. Wygod reported disposing of a total of 1,528,927 shares of common stock back to the company in connection with its acquisition by 2025 Acquisition Company, LLC. The transactions reflect cancellation of shares at the merger’s effective time, leaving him with no reported common stock holdings. Unvested restricted stock units were converted into a right to receive cash based on a price of $2.17 per underlying share.
Forian Inc. director Ian Banwell reported disposing of his holdings in connection with the company’s cash merger. On May 15, 2026, common shares, including 99,784 shares held indirectly by his spouse and 5,000 shares held directly, were tendered in a completed tender offer at $2.17 per share in cash. The filing also shows several stock option awards, each covering 15,000 shares of common stock, were disposed of back to the issuer pursuant to the merger agreement. Under the merger terms, vested options with an exercise price below the Offer Price became entitled to a cash payment, while unvested options or those with an exercise price equal to or above $2.17 were cancelled without consideration. Following these transactions, the report shows Banwell with zero common shares and no remaining listed stock options.
Forian Inc. director Jennifer Hajj reported the disposal of common stock and stock options in connection with a cash tender offer and merger. She reported 5,000 shares of common stock held indirectly by her spouse and 5,000 shares held directly, all disposed of pursuant to a tender offer.
Footnotes state that shareholders received $2.17 per share in cash in the offer, after which a merger made Forian a wholly owned subsidiary of the acquiring parent. At the merger’s effective time, vested stock options with an exercise price below the $2.17 offer price were cancelled in exchange for cash based on the spread, while unvested or higher-priced options were cancelled without payment.
Hajj also reported disposition to the issuer of multiple stock option awards, each covering 15,000 shares of common stock, with exercise prices ranging from $12.18 to $2.06 per share. Following these transactions, the filing shows zero shares and zero options remaining under the reported entries.
Forian Inc. director Mark J. Adler reported disposing of his stake in connection with the company’s acquisition. On May 15, 2026, he tendered 37,583 shares of common stock into Parent’s tender offer at an offer price of $2.17 per share in cash.
At the merger’s Effective Time, his vested stock options were cancelled. Options with an exercise price below the $2.17 offer, including grants at $2.06 per share, were converted into a cash right per the merger formula, while higher‑priced or unvested options were cancelled without payment. Following these transactions, Adler holds no Forian common shares or options.
Forian Inc.'s Chief Financial Officer, Michael Vesey, has fully exited his equity position as part of the company’s cash acquisition. On May 15, 2026, he disposed of 139,610 shares of common stock in the tender offer at a cash price of $2.17 per share, and a further 450,000 common shares were disposed to the issuer, leaving him with no common stock reported.
All reported stock options were also disposed to the issuer, including 350,000 options at $10.62, 200,000 options at $2.98, 185,000 options at $3.79, and 175,000 options at $2.67 per share, each with future expiration dates. Footnotes explain that, under the merger agreement, the tender offer at $2.17 per share was followed by a merger in which unvested RSUs were cashed out and certain underwater or unvested options were canceled in connection with Forian becoming a wholly owned subsidiary of the buyer.
Forian Inc. director Kristiina Vuori reported disposing of her equity in connection with the company’s cash tender offer and merger. She tendered 28,757 shares of common stock, which, under the merger terms, entitled shareholders to receive $2.17 per share in cash. Multiple stock option grants covering 15,000 shares each, with exercise prices between $2.06 and $12.18, were also disposed of or cancelled pursuant to the merger agreement. Following these transactions, the filing shows she holds zero shares and zero stock options directly.
Forian Inc. director Alyssa F. Varadhan reported the cash tender and cancellation of her equity in connection with the company’s merger. She disposed of 5,000 shares of common stock in a tender offer in which shareholders received $2.17 per share in cash.
On the same date, several stock option grants covering 15,000 shares each, with exercise prices ranging from $12.18 to $2.06 per share, were disposed of to the issuer under the merger terms. Vested options with exercise prices below $2.17 were converted into cash equal to the spread, while unvested or out-of-the-money options were cancelled without payment, leaving her with no reported remaining holdings or options.
Forian Inc. director and Chief Strategy Officer Adam H. Dublin reported dispositions of common stock in connection with the company’s merger and going‑private transaction. On May 15, 2026, entities associated with Dublin and his direct holdings transferred a total of several million shares back to the issuer at a stated price of $0.00 per share as “dispositions to issuer,” leaving zero reported shares owned after the transactions. The footnotes explain that Dublin had previously contributed all his Forian shares into 2025 Acquisition Company, LLC, which completed a tender offer and merger that made Forian a wholly owned subsidiary. Unvested restricted stock units were cancelled at the merger’s effective time and converted into a cash right equal to the number of units multiplied by $2.17 per share.